- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 blockade in ocular inflammatory diseases
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 176, Issue 3, Pages 301-309
Publisher
Wiley
Online
2014-02-17
DOI
10.1111/cei.12295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transcriptional Complex Formation of c-Fos, STAT3, and Hepatocyte NF-1 Is Essential for Cytokine-Driven C-Reactive Protein Gene Expression
- (2014) T. Nishikawa et al. JOURNAL OF IMMUNOLOGY
- Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab
- (2014) Sumiyuki Nishida et al. Modern Rheumatology
- A case of Behçet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab
- (2014) Toru Hirano et al. Modern Rheumatology
- Successful treatment with tocilizumab in a case of Cogan’s syndrome complicated with aortitis
- (2014) Mihoko Shibuya et al. Modern Rheumatology
- Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases
- (2013) Rieke Alten et al. ANNALS OF MEDICINE
- Tocilizumab treatment for refractory uveitis-related cystoid macular edema
- (2013) Alfredo Adán et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: a case report
- (2013) Alfredo Adán et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Can IL-6 blockade rectify imbalance between Tregs and Th17 cells?
- (2013) Toshio Tanaka Immunotherapy
- Effective Control of Polymyalgia Rheumatica With Tocilizumab
- (2013) Abdulrahman Al Rashidi et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Treatment of Relapsing Polychondritis with Tocilizumab
- (2013) D. WENDLING et al. JOURNAL OF RHEUMATOLOGY
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan
- (2013) T. Koike et al. JOURNAL OF RHEUMATOLOGY
- Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases
- (2013) Yasuaki Okuda et al. Modern Rheumatology
- Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
- (2013) Xin Yao et al. PHARMACOLOGY & THERAPEUTICS
- Efficacité clinique et biologique du tocilizumab au cours de la maladie de Horton : à propos de trois observations et revue de la littérature
- (2013) P. Kieffer et al. REVUE DE MEDECINE INTERNE
- Tocilizumab in rheumatoid arthritis: A meta-analysis of efficacy and selected clinical conundrums
- (2013) Geraldine Navarro et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Current perspectives on tocilizumab for the treatment of rheumatoid arthritis: a review
- (2013) Al-Shakarchi et al. Patient Preference and Adherence
- Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
- (2012) Lisa Kaly et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- CD8+CD28− Lymphocytes in Peripheral Blood and Serum Concentrations of Soluble Interleukin 6 Receptor are Increased in Patients with Graves’ Orbitopathy and Correlate with Disease Activity
- (2012) Miroslaw Slowik et al. ENDOCRINE RESEARCH
- Increased serum interleukin-17 in Graves’ ophthalmopathy
- (2012) Sung Eun Kim et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Tocilizumab treatment for recalcitrant uveitic macular edema
- (2012) Alfredo Adán et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
- (2012) Toshio Tanaka et al. International Journal of Biological Sciences
- Induction of severe systemic lupus erythematosus by TNF blockade and response to anti–IL-6 strategy
- (2012) Sabine Adler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Is Tocilizumab an Effective Option for Treatment of Refractory Uveitis Associated with Juvenile Idiopathic Arthritis?
- (2012) C. TAPPEINER et al. JOURNAL OF RHEUMATOLOGY
- Tocilizumab for treating refractory haemolytic anaemia in a patient with systemic lupus erythematosus
- (2012) F. J. Garcia-Hernandez et al. RHEUMATOLOGY
- Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica
- (2012) Bernd C. Kieseier et al. JAMA Neurology
- Blockade of Interleukin-6 Receptor Alleviates Disease in Mouse Model of Scleroderma
- (2011) Shun Kitaba et al. AMERICAN JOURNAL OF PATHOLOGY
- Human FoxP3+ regulatory T cells in systemic autoimmune diseases
- (2011) Makoto Miyara et al. AUTOIMMUNITY REVIEWS
- Tocilizumab for the Treatment of Steroid Refractory Graft-versus-Host Disease
- (2011) William R. Drobyski et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cytokines in Autoimmune Uveitis
- (2011) Reiko Horai et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Efficacy of Tocilizumab in Two Patients with anti-TNF-alpha Refractory Uveitis
- (2011) Aurore Muselier et al. OCULAR IMMUNOLOGY AND INFLAMMATION
- Therapeutic effect of tocilizumab on two patients with polymyositis
- (2011) M. Narazaki et al. RHEUMATOLOGY
- Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab
- (2010) A. Ogata et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses
- (2010) Satoshi Hohki et al. EXPERIMENTAL EYE RESEARCH
- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
- (2010) Shigeru Kotake et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Influence of Excessive IL-6 Production In Vivo on the Development and Function of Foxp3+ Regulatory T Cells
- (2010) M. Fujimoto et al. JOURNAL OF IMMUNOLOGY
- The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
- (2010) Y. Shima et al. RHEUMATOLOGY
- Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
- (2010) L. Campbell et al. RHEUMATOLOGY
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis
- (2009) T. Yoshimura et al. RHEUMATOLOGY
- Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses
- (2008) Minoru Fujimoto et al. ARTHRITIS AND RHEUMATISM
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
- (2008) Shumpei Yokota et al. LANCET
- IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis
- (2008) Satoshi Serada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started